AI-Driven Plant-Derived Anti-Infectives: Integrating Traditional Wisdom into Precision Medicine Against AMR
Life · 25.03.2026 · 16 (4) · 540
DOI: 10.3390/life16040540 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 25.03.2026. Verfasst von Zhiwu Yin und 5 weiteren Autor:innen. Beteiligte Einrichtung: Netclass Technology Inc., Shanghai 200072, China. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 114 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Chinese Academy of Sciences President's International Fellowship Initiative, Chinese Academy of Sciences President’s International Fellowship Initiative.
Abstract (Originalsprache)
The escalating antimicrobial resistance (AMR) crisis necessitates the development of innovative anti-infectives with novel mechanisms of action. Nevertheless, research on natural products remains constrained by low-throughput screening and limited mechanistic insights. Artificial intelligence (AI) is catalyzing a pivotal paradigm shift—from the mere isolation of active compounds to precisely deciphering their modes of action. This review highlights AI’s transformative role in bridging ethnopharmacological knowledge and modern pharmacology to decode the mechanisms of plant-derived anti-infectives. Case studies on berberine, baicalein, danshensu derivatives, and rosmarinic acid derivatives from Coleus amboinicus illustrate AI’s capacity to map traditional therapeutic concepts to specific pathways (e.g., biofilm inhibition, inflammasome modulation) and to predict precise binding interactions and pharmacophores with high precision. Leveraging statistical correlations between ethnobotanical usage patterns and chemical similarity, we propose a “Knowledge–Data–Mechanism” three-layer framework centered on deep mechanistic insight. Integrating Chinese initiatives, such as the CNDR (China’s National Drug Repository) database and the TCM-AI platform, with global traditional medicine wisdom, this strategy provides an actionable roadmap for modernizing anti-infective discovery. Validated applications of this paradigm have demonstrated order-of-magnitude acceleration in mechanistic characterization, rapidly yielding structurally novel agents with well-defined, target-specific actions—a critical advancement in addressing the urgent global threat of antimicrobial resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Netclass Technology Inc., Shanghai 200072, China.
- Academy for Smart Health and Longevity R&D, University of Saint Joseph, Macao SAR, China.
- Shanghai Institute of Immunity and Infection, Chinese Academy of Sciences, Shanghai 201203, China.
- School of Computer Engineering and Science, Shanghai University, Shanghai 200444, China.
- Computer Science Department, School of Sciences and Technology, University of Évora, Rua Romão Ramalho 59, 7000-671 Évora, Portugal.
ORCID-Profile: Zhiwu Yin, Changbin Chen, Xing Wu, Paulo Quaresma, Jianbiao Dai
Förderung
- Chinese Academy of Sciences President's International Fellowship Initiative
- Chinese Academy of Sciences President’s International Fellowship Initiative
Zitieren
APA
Yin, Z., Chen, C., Wu, X., Luo, W., Quaresma, P., & Dai, J. (2026). AI-Driven Plant-Derived Anti-Infectives: Integrating Traditional Wisdom into Precision Medicine Against AMR. Life, 16(4), 540. https://doi.org/10.3390/life16040540
Vancouver
Yin Z, Chen C, Wu X, Luo W, Quaresma P, Dai J. AI-Driven Plant-Derived Anti-Infectives: Integrating Traditional Wisdom into Precision Medicine Against AMR. Life. 2026;16(4):540. doi:10.3390/life16040540
BibTeX
@article{Yin2026,
author = {Yin, Zhiwu and Chen, Changbin and Wu, Xing and Luo, Wenhao and Quaresma, Paulo and Dai, Jianbiao},
title = {AI-Driven Plant-Derived Anti-Infectives: Integrating Traditional Wisdom into Precision Medicine Against AMR},
journal = {Life},
year = {2026},
volume = {16},
number = {4},
pages = {540},
doi = {10.3390/life16040540}
}
EUVIMED